DAVITA INC. Net Cash Provided by (Used in) Investing Activities, Continuing Operations
DAVITA INC. (DVA) reported Net Cash Provided by (Used in) Investing Activities, Continuing Operations of $3.13 billion for the 9-month period ending 2019-09-30, per its 10-Q filed 2019-11-07.
Discontinued › Cash Flow › Investing Activities
us-gaap:NetCashProvidedByUsedInInvestingActivitiesContinuingOperations · last filed 2019-11-07
- DAVITA INC. net cash provided by (used in) investing activities, continuing operations for the quarter ending 2019-09-30 was -$268.67M.
- DAVITA INC. net cash provided by (used in) investing activities, continuing operations for the quarter ending 2019-06-30 was $3.60B.
- DAVITA INC. net cash provided by (used in) investing activities, continuing operations for the quarter ending 2019-03-31 was -$200.36M.
- DAVITA INC. net cash provided by (used in) investing activities, continuing operations for the quarter ending 2018-09-30 was -$237.25M.
- DAVITA INC. net cash provided by (used in) investing activities, continuing operations for fiscal 2016 was -$1.20B.
- DAVITA INC. net cash provided by (used in) investing activities, continuing operations for fiscal 2015 was -$881.78M.
- DAVITA INC. net cash provided by (used in) investing activities, continuing operations for fiscal 2014 was -$1.28B.
- DAVITA INC. net cash provided by (used in) investing activities, continuing operations for fiscal 2013 was -$876.88M.
| Period end | Net Cash Provided by (Used in) Investing Activities, Continuing Operations 3 month | Net Cash Provided by (Used in) Investing Activities, Continuing Operations 3 month as first filed | Net Cash Provided by (Used in) Investing Activities, Continuing Operations 6 month | Net Cash Provided by (Used in) Investing Activities, Continuing Operations 6 month as first filed | Net Cash Provided by (Used in) Investing Activities, Continuing Operations 9 month | Net Cash Provided by (Used in) Investing Activities, Continuing Operations 9 month as first filed | Net Cash Provided by (Used in) Investing Activities, Continuing Operations 12 month |
|---|---|---|---|---|---|---|---|
| 2019-09-30 | -$268.67M derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-07 | $3.33B derived: sum of 2 quarters · filed 2019-11-07 | $3.13B 10-Q · filed 2019-11-07 | ||||
| 2019-06-30 | $3.60B derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-02 | $3.40B 10-Q · filed 2019-08-02 | |||||
| 2019-03-31 | -$200.36M 10-Q · filed 2019-05-07 | ||||||
| 2018-09-30 | -$237.25M derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-07 | -$461.19M derived: sum of 2 quarters · filed 2019-11-07 | -$661.32M 10-Q · filed 2019-11-07 | ||||
| 2018-06-30 | -$223.94M derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-02 | -$424.06M 10-Q · filed 2019-08-02 | |||||
| 2018-03-31 | -$200.13M 10-Q · filed 2019-05-07 | ||||||
| 2017-09-30 | -$253.94M derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-07 | -$855.56M derived: sum of 2 quarters · filed 2018-11-07 | -$1.11B 10-Q · filed 2018-11-07 | -$1.11B 10-Q · filed 2017-11-07 | -$1.05B derived: sum of 4 quarters · filed 2018-11-07 | ||
| 2017-06-30 | -$601.62M derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-01 | -$851.61M 10-Q · filed 2018-08-01 | -$851.65M 10-Q · filed 2017-08-01 | -$796.03M derived: sum of 3 quarters · filed 2018-08-01 | -$1.30B derived: sum of 4 quarters · filed 2018-08-01 | ||
| 2017-03-31 | -$249.99M 10-Q · filed 2018-05-03 | -$250.01M 10-Q · filed 2017-05-02 | -$194.41M derived: sum of 2 quarters · filed 2018-05-03 | -$693.43M derived: sum of 3 quarters · filed 2018-05-03 | -$897.34M derived: sum of 4 quarters · filed 2018-05-03 | ||
| 2016-12-31 | $55.57M derived: 10-K 12 month − 10-Q 9 month · filed 2017-02-24 | -$443.44M derived: sum of 2 quarters · filed 2017-11-07 | -$647.36M derived: sum of 3 quarters · filed 2017-11-07 | -$1.20B 10-K · filed 2017-02-24 | |||
| 2016-09-30 | -$499.01M derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-07 | -$702.93M derived: sum of 2 quarters · filed 2017-11-07 | -$1.26B 10-Q · filed 2017-11-07 | -$988.64M derived: sum of 4 quarters · filed 2017-11-07 | |||
| 2016-06-30 | -$203.92M derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-01 | -$758.23M 10-Q · filed 2017-08-01 | -$489.63M derived: sum of 3 quarters · filed 2017-08-01 | -$692.68M derived: sum of 4 quarters · filed 2017-08-01 | |||
| 2016-03-31 | -$554.31M 10-Q · filed 2017-05-02 | -$285.71M derived: sum of 2 quarters · filed 2017-05-02 | -$488.76M derived: sum of 3 quarters · filed 2017-05-02 | -$1.18B derived: sum of 4 quarters · filed 2017-05-02 | |||
| 2015-12-31 | $268.60M derived: 10-K 12 month − 10-Q 9 month · filed 2017-02-24 | $65.55M derived: sum of 2 quarters · filed 2017-02-24 | -$629.50M derived: sum of 3 quarters · filed 2017-02-24 | -$881.78M 10-K · filed 2017-02-24 | |||
| 2015-09-30 | -$203.05M derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-02 | -$898.10M derived: sum of 2 quarters · filed 2016-11-02 | -$1.15B 10-Q · filed 2016-11-02 | -$1.60B derived: sum of 4 quarters · filed 2017-02-24 | |||
| 2015-06-30 | -$695.05M derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-08 | -$947.34M 10-Q · filed 2016-08-08 | -$1.39B derived: sum of 3 quarters · filed 2017-02-24 | -$1.78B derived: sum of 4 quarters · filed 2017-02-24 | |||
| 2015-03-31 | -$252.29M 10-Q · filed 2016-05-04 | -$698.83M derived: sum of 2 quarters · filed 2017-02-24 | -$1.09B derived: sum of 3 quarters · filed 2017-02-24 | ||||
| 2014-12-31 | -$446.54M derived: 10-K 12 month − 10-Q 9 month · filed 2017-02-24 | -$834.87M derived: sum of 2 quarters · filed 2017-02-24 | -$1.28B 10-K · filed 2017-02-24 | ||||
| 2014-09-30 | -$388.33M derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-05 | -$831.18M 10-Q · filed 2015-11-05 | |||||
| 2014-06-30 | -$442.86M 10-Q · filed 2015-08-05 | ||||||
| 2013-12-31 | -$876.88M 10-K · filed 2016-02-26 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Sotera Health Co (SHC) | United States | $5.271B | 30.96 |
| Progyny, Inc. (PGNY) | United States | $1.994B | 28.37 |
| agilon health, inc. (AGL) | United States | $1.272B | -7.76 |
| VIEMED HEALTHCARE, INC. (VMD) | United States | $0.336B | 29.92 |
| Park Dental Partners, Inc. (PARK) | United States | $0.094B | |
| BioRestorative Therapies, Inc. (BRTX) | United States | $0.064B | |
| CRYO CELL INTERNATIONAL INC (CCEL) | United States | $0.033B | -11.02 |
| MANGOCEUTICALS, INC. (MGRX) | United States | $0.010B | -0.43 |